BioVoice

BioVoice is a standalone media platform dedicated to reporting on the Indian bioscience industry. It features a constantly updated web portal, a digital magazine published twice a year, and an upcoming mobile app. Established in 2015, this dynamic news source bridges the gaps in communication within the bioscience sector, providing more opportunities for engagement and information sharing.

National

English

Online/Digital

Outlet metrics

Domain Authority

Ranking

Global

#3683093

India

#320416

Science and Education/Biology

#954

Traffic sources

Monthly visitors

Articles

“Patent expiry of significant number of biologics by 2030 is a huge opportunities for biosimilars players"

6 days ago | biovoicenews.com | Rahul Koul

In an exclusive interview, Dr Cyrus Karkaria, President-Biotechnology, Lupin Limited shares his views on the current market trends and growth prospects of Indian biosimilars industry, company’s key offerings, ongoing initiatives, and future plansYour views on the current state and trends of India’s biosimilars industry, and how can it capitalize on emerging opportunities? India’s biosimilars industry is currently experiencing significant growth and transformation.
"Biosimilars set to gain as key biologics lose patents by 2030"

6 days ago | biovoicenews.com | Rahul Koul

In an exclusive interview, Dr Cyrus Karkaria, President-Biotechnology, Lupin Limited shares his views on the current market trends and growth prospects of Indian biosimilars industry, company’s key offerings, ongoing initiatives, and future plansYour views on the current state and trends of India’s biosimilars industry, and how can it capitalize on emerging opportunities? India’s biosimilars industry is currently experiencing significant growth and transformation.
MTaI calls for nuanced stance on DGHS's ban of medical representatives from entering central govt hospitals

1 week ago | biovoicenews.com | Rahul Koul

New Delhi: Reacting to the the recent directive by the Directorate General of Health Services (DGHS) restricting the entry of medical representatives into government hospitals, the Medical Technology Association of India (MTaI) has called for a more nuanced and differentiated approach-especially concerning the medical devices and equipment sector. “Medical technologies today are not static products; they are evolving systems deeply integrated into clinical workflows.
"Medtronic invested US$ 510 million in its Hyderabad facility, making it our largest R&D hub outside the U.S."

3 weeks ago | biovoicenews.com | Rahul Koul

In an exclusive interaction, Mandeep Singh Kumar, Managing Director and Vice President, Medtronic India shared insights on the company’s key milestones, its key offerings, upcoming initiatives, major investments and future plans. Key milestones achieved by Medtronic India in the last few years? Medtronic is making remarkable progress in India, showcasing its steadfast dedication to advancing healthcare.
“Our research specifically focuses on understanding how gene function changes with age”

2 months ago | biovoicenews.com | Rahul Koul

In an exclusive interview, Shailendra Vyas CEO and Director, Bioheaven360 Genotec shares details on thecompany’s journey so far, its key offerings, upcoming initiatives, and future plans. What motivated you to take up the challenge of founding a startup? Please share your foundational story with our readers.
“We have invested about $31 million globally including India to enhance research facilities”

2 months ago | biovoicenews.com | Rahul Koul

In an exclusive interview, Dr Anil Gulati, Chairman and CEO, Pharmazz Inc. answers our questions on the company’s current operations in India and globally, its R&D initiatives, key disease areas and long-term plans. Pharmazz has been at the forefront of developing innovative therapies for critical conditions. Could you elaborate on your most recent product developments? Pharmazz, Inc.
“The integration of genomics into healthcare will revolutionize personalized care ”

2 months ago | biovoicenews.com | Rahul Koul

In an exclusive interview, Kishore Karumanchi, CEO of aciana shares details on thecompany’s key offerings, upcoming initiatives, technology trends and future plans. What sets aciana apart in the industry and your recent initiatives or technologies that have been pivotal? aciana revolutionizes healthcare with its genetic-based approach and advanced analytics that drive insights across the entire healthcare ecosystem.
Samunnati raises Rs 2,300 crore in FY25, strengthening its position in agri-ecosystem

2 months ago | biovoicenews.com | Rahul Koul

New Delhi: Samunnati, India’s pioneering agri-value chain enabler, has successfully raised INR 2,300 crore in debt funding during FY25, marking a 50% increase over the previous year. It has diversified its sources of lending, leveraging debt market instruments, securitization, and increased bank exposure, which has enabled it to onboard 12 new prominent lenders, bringing the total lender relationships to 46.
FACE TO FACE: Dr Taslimarif Saiyed, Director and CEO, Centre for Cellular and Molecular Platforms (C-CAMP) - BioVoiceNews

Mar 31, 2025 | biovoicenews.com | Rahul Koul

In an exclusive interview, Rahul Koul, Chief Editor, BioVoice News spoke to Taslimarif Saiyed, Director and CEO, Centre for Cellular and Molecular Platforms (C-CAMP) on the relevance of Startup Mahakumbh event, key factors driving startup ecosystem, challenges and much more. Key talk points:♦ Startup Mahakumbh, world’s largest startup event is happening from 3rd to 5th April 2025 in New Delhi.
India’s Push for Eradicating Tuberculosis

Mar 18, 2025 | biovoicenews.com | Rahul Koul

New Delhi: In 2023, Tuberculosis (TB) reclaimed its position as the leading cause of death from a single infectious agent, surpassing COVID-19, with 1.25 million fatalities worldwide. India, contributing over a quarter of global TB cases, remains a hotspot. Meanwhile, the advancements in treatment, including discovery of the novel drug Bedaquiline, have significantly improved drug-resistant TB management as well as overall survival rates in these patients.

BioVoice journalists

Rahul Koul

Contact details

Address

123 Example Street

City, Country 12345

Email

[email protected]

Contact Forms

Contact Form

Website

http://biovoicenews.com

Socials

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

BioVoice

Outlet metrics

Articles

“Patent expiry of significant number of biologics by 2030 is a huge opportunities for biosimilars players"

"Biosimilars set to gain as key biologics lose patents by 2030"

MTaI calls for nuanced stance on DGHS's ban of medical representatives from entering central govt hospitals

"Medtronic invested US$ 510 million in its Hyderabad facility, making it our largest R&D hub outside the U.S."

“Our research specifically focuses on understanding how gene function changes with age”

“We have invested about $31 million globally including India to enhance research facilities”

“The integration of genomics into healthcare will revolutionize personalized care ”

Samunnati raises Rs 2,300 crore in FY25, strengthening its position in agri-ecosystem

FACE TO FACE: Dr Taslimarif Saiyed, Director and CEO, Centre for Cellular and Molecular Platforms (C-CAMP) - BioVoiceNews

India’s Push for Eradicating Tuberculosis